John A Gonzales Selected Research

Antimetabolites

1/2022	Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial.
1/2022	Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.
1/2021	Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for Uveitis.
10/2019	Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
7/2017	Quality-of-Life Outcomes From a Randomized Clinical Trial Comparing Antimetabolites for Intermediate, Posterior, and Panuveitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John A Gonzales Research Topics

Disease

14	Uveitis 07/2022 - 07/2017
8	Inflammation (Inflammations) 07/2022 - 06/2018
5	Panuveitis 06/2020 - 01/2017
4	Dry Eye Syndromes (Dry Eye Syndrome) 03/2022 - 01/2018
4	Anterior Uveitis 01/2021 - 06/2018
3	Macular Edema 01/2022 - 01/2019
2	Lymphoma (Lymphomas) 01/2021 - 01/2006
2	Disease Progression 01/2020 - 01/2015
2	Intermediate Uveitis (Chronic Cyclitis) 10/2019 - 01/2019
2	Scleritis (Episcleritis) 06/2018 - 01/2017
1	Glaucoma 06/2022
1	Hyphema 06/2022
1	Leptospirosis 04/2022
1	Corneal Injuries 01/2022
1	Ulcer 01/2022
1	Birdshot Chorioretinopathy 02/2021
1	Cytopenia 01/2021
1	Eye Infections 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Virus Diseases (Viral Diseases) 10/2020
1	Vasculitis (Vasculitides) 08/2020
1	Retinal Vasculitis 08/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2020
1	Retinal Detachment (Retinal Detachments) 06/2020
1	Retinal Perforations 06/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Renal Insufficiency (Renal Failure) 12/2019
1	Posterior Uveitis 10/2019
1	Ocular Hypertension (Glaucoma, Suspect) 11/2018
1	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 11/2018
1	Retinitis 11/2018
1	Neoplasms (Cancer) 06/2018
1	Dental Caries (Decay, Dental) 01/2018
1	Necrosis 10/2012
1	Chickenpox 10/2012
1	Herpes Zoster 10/2012
1	Toxocariasis 09/2012
1	Chalazion 01/2011
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2006
1	Orbital lymphoma 01/2006
1	Infections 01/2006

Drug/Important Bio-Agent (IBA)

6	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 07/2017
6	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 07/2017
5	SteroidsIBA 07/2022 - 11/2018
5	AntimetabolitesIBA 01/2022 - 07/2017
3	Valganciclovir FDA Link 01/2021 - 12/2019
3	Prednisone (Sone)FDA LinkGeneric 08/2020 - 06/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2020 - 10/2019
2	Fluorescein (Funduscein)FDA LinkGeneric 07/2022 - 01/2019
2	RNA (Ribonucleic Acid)IBA 06/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2006
2	Retinaldehyde (Retinal)IBA 01/2019 - 10/2012
2	AntigensIBA 01/2018 - 01/2006
1	Fluocinolone Acetonide (Capex)FDA LinkGeneric 07/2022
1	AntibodiesIBA 03/2022
1	HLA-A29 antigenIBA 02/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2021
1	letermovirIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	IceIBA 10/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2020
1	Immune Checkpoint InhibitorsIBA 08/2020
1	IpilimumabIBA 08/2020
1	FibrinIBA 06/2020
1	durvalumabIBA 01/2020
1	SolutionsIBA 12/2019
1	Ganciclovir (Cytovene)FDA LinkGeneric 12/2019
1	Immunoglobulin A (IgA)IBA 12/2019
1	AutoantibodiesIBA 12/2019
1	Immunoglobulin M (IgM)IBA 12/2019
1	Pharmaceutical PreparationsIBA 10/2019
1	prednisolone acetate FDA LinkGeneric 10/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	Antiviral Agents (Antivirals)IBA 11/2018
1	NivolumabIBA 06/2018
1	cabiralizumabIBA 06/2018
1	Antinuclear AntibodiesIBA 01/2018
1	Rheumatoid FactorIBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	Hemostatics (Antihemorrhagics)IBA 01/2011
1	octyl 2-cyanoacrylateIBA 01/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2006

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2006
3	Immunomodulation 10/2019 - 01/2015
1	Intraocular Lenses (Intraocular Lens) 06/2022
1	Intravitreal Injections 08/2020
1	Vitrectomy 06/2020
1	Injections 11/2018
1	Immunotherapy 06/2018
1	Operative Surgical Procedures 09/2012